林勇：饲料养殖 如何降本增效， 富泉以控释缓释 技术助力营养高 效利用┃穗风不 惑_南方+_南方 plus 编者按：四十年 栉风沐雨，羊城 饲界潮涌珠江。 改革开放以来， 广州饲料产业乘 势而上，谱写奋 进史诗。依托技 术创新，穗风动 物营养星火燎 原，从本土走向 世界。浪潮之 中，广州市饲料 行业协会激荡四 十年，成为行业 发展标杆。为总 结协会及广州饲 料行业发展成 果，洞察行业走 势，南方农村报 推出"穗风·不 惑"系列报道。 以协会为镜，观 行业之变；以广 州为窗，察饲界 之势。敬请垂 注。 "依靠工艺技术 手段，提高动物 营养的有效利用 率，可以帮助农 牧企业实现增效 降本。"广州市 饲料行业协会秘 书长、广州市富 泉生物科技有限 公司（简称"富 泉生物"）总经 理林勇说。2003 年至今，富泉生 物以"控释、缓 释、融合、包 膜"等工艺创新 为笔，在动物营 养高效利用的赛 道上书写技术深 耕的答卷。 伴随广州饲料行 业从增量扩张到 提质升级，林勇 带领富泉生物突 围，也深度参与 广州市饲料行业 协会工作，推动 技术落地与合作 交流。而富泉生 物二十余年的实 践表明，饲料添 加剂行业的永恒 赛道，终 ...

内容概要：当前，中国正逐步减少在养殖中使用抗生素，养殖企业积极寻找安全高效的替代方案。饲料 酸化剂通过降低消化道pH值、抑制有害微生物、促进营养吸收，成为重要的替代选择。同时，饲料行 业整体向"提质增效"转型，对饲料配方的精细化、专业化要求提高。酸化剂能有效提升饲料蛋白转化效 率，降低饲料成本，符合饲料行业降本增效的核心诉求。此外，国家加强了对饲料投入品的监管，并鼓 励推广新型安全高效添加剂，为酸化剂等合规、安全的产品提供了良好的发展环境。在此背景下，饲料 酸化剂行业市场规模持续上涨。2025年中国饲料酸化剂行业市场规模达到46.12亿元，同比上涨 12.65%。 相关上市企业：美农生物（301156）、大北农（002385）、牧原股份（002714）、温氏股份 （300498）、新希望（000876）、天邦食品（002124）、唐人神（002567）、新五丰（600975）、中牧 股份（600195）等。 相关企业：潍坊加易加生物科技有限公司、生物源生物技术(深圳)股份有限公司、上海正正生物技术有 限公司、河南星汉生物科技有限公司、重庆民泰新农业科技发展集团有限公司、成都大帝汉克生物科技 有限公司、广州市佰 ...

转自：南昌发布 慰问关怀暖人心 凝心聚力促发展 李红军在南昌县开展春节前走访慰问活动 2月8日，省人大常委会副主任、南昌市委书记、赣江新区党工委书记李红军前往南昌县开展春节前走访慰问活动，看望慰问部分全国人大代表、高层次人 才、老党员以及企业家等，向他们送去党和政府的关怀与温暖，并致以诚挚问候和新春祝福。市委副书记党静参加。 江西天佳生物工程股份有限公司是一家以生物技术为依托，集饲料添加剂的研究、开发、生产和贸易为一体的高科技股份制企业，在可替抗饲料添加剂及 其制剂技术研究方面处于国内前列。李红军察看企业生产车间和成品库，了解企业发展中遇到的困难和问题，鼓励企业坚定信心、抢抓机遇，积极创新产 品和技术，积极对接拓展海外市场，努力抢占更大市场份额。李红军要求有关部门要及时了解企业诉求，帮助企业纾困解难，全力支持企业技改升级，推 动发展提质增效，昂首奋进"十五五"新征程。 今年80岁的老党员李友生曾是抗美援越战士，荣立三等功。在李友生家中，李红军与老人拉家常，关切询问老人的家庭生活、身体健康等情况，认真倾听 老党员讲述过去的奋斗故事，感谢他为党和人民的事业作出的贡献，并送上慰问金，希望他保重身体、幸福生活，继续发 ...

Group 1 - The core viewpoint of the article is that Garden Biologics (300401.SZ) has not yet generated revenue from its feed-grade cholesterol in the domestic market [1] - Feed-grade cholesterol is used as an additive in animal feed, with downstream applications primarily in premix and feed production manufacturers [1]

Core Viewpoint - The company has not yet generated revenue from its feed-grade cholesterol product, which is intended as an additive for animal feed [2]. Group 1: Company Information - The company, Huayuan Biological (花园生物), confirmed that its feed-grade cholesterol has not yet produced revenue domestically [2]. - The primary downstream customers for feed-grade cholesterol include premix and feed manufacturers [2].

Core Insights - The report titled "2026-2032 China Feed Additives Industry Panorama Research and Market Analysis Forecast" provides a comprehensive overview of the feed additives industry, including market development environment, operational status, competitive landscape, key enterprise performance, and future trends and investment forecasts [2] Group 1: Industry Overview - The report introduces the definition, types, and basic functions of feed additives, highlighting their importance in animal nutrition [2] - It discusses the production processes of feed additives and factors leading to spoilage during feed processing [2] Group 2: Global Market Position and Forecast - China holds the position of the world's largest feed producer, with a significant focus on feed additives development in Asia [3] - The report predicts a continued emphasis on amino acids, vitamins, and enzyme preparations, alongside stricter regulations on drug feed additives [3][4] Group 3: Current Status and Trends in China - The Chinese feed additives industry is facing challenges such as high production costs and increased competition, leading to a concentration of resources and capital [4] - The report identifies a shift towards professionalized breeding, the development of unconventional feed resources, and a focus on low-carbon and environmentally friendly production methods [4] Group 4: Future Directions - Future trends in feed additives include the increased role of amino acids, the monopolization of vitamin production, and the widespread application of enzyme preparations [5][10] - The report emphasizes the need for innovation in green feed additives and the importance of addressing safety concerns related to feed additives [6][10] Group 5: Competitive Landscape - The competitive landscape of the global feed additives market is characterized by the presence of major animal nutrition companies, each with distinct development strategies [3] - The report highlights the necessity for companies to adapt to changing market dynamics and consumer preferences to maintain competitiveness [9]

Core Viewpoint - The company has received production approval for sodium chlorogenic acid as a new feed additive, indicating a significant advancement in its product offerings and market potential [2]. Group 1: Product Development - The company officially obtained production licensing for sodium chlorogenic acid as a new feed additive on December 29, 2025 [2]. - The product exhibits clear antioxidant, anti-inflammatory, and antiviral functions, suggesting a broad market outlook in the feed additive sector [2]. Group 2: Production Technology - Sodium chlorogenic acid is a byproduct of the steviol glycosides production process, utilizing the company's self-developed short-chain alcohol mixed solution extraction technology [2]. - This technology allows for resource integration while ensuring the main product's production, demonstrating good unit efficiency [2].

Core Viewpoint - Hengtong Co., Ltd. (stock code: 600226) primarily engages in the production and sales of electrolytic copper foil, veterinary pharmaceuticals, feed additives, and related businesses such as cogeneration [1] Group 1 - The main business segments of the company include electrolytic copper foil production [1] - The company also produces and sells veterinary pharmaceuticals [1] - Feed additives are another key product line for the company [1] - The company is involved in cogeneration-related businesses [1]

Core Viewpoint - The company plans to invest 50 million yuan to establish a wholly-owned subsidiary in Hohhot, Inner Mongolia, aimed at enhancing production capacity and resource allocation in the veterinary medicine and feed additive sectors [1] Group 1: Investment Details - The registered capital of the new subsidiary will be 50 million yuan, with a 100% ownership stake by the company [1] - The investment is intended to leverage the advantages of the company's Phase VI project and improve cost management and operational efficiency [1] Group 2: Strategic Alignment - This initiative aligns with the company's overall development strategy and aims to expand its business layout in veterinary medicine and feed additives [1] - The establishment of the subsidiary does not require shareholder approval and is not classified as a related party transaction or a major asset restructuring [1] Group 3: Risk Management - The new subsidiary is subject to the completion of business registration, which carries certain market and operational risks [1] - The company will enhance internal controls and risk prevention mechanisms to mitigate potential risks [1]

Core Viewpoint - The report from Dongwu Securities highlights the robust development of Andisu's dual pillar strategy, with the Quanzhou solid methionine project opening up growth opportunities [1] Group 1: Business Growth - The company continues to increase its investment in research and innovation, laying a foundation for future business growth [1] - The penetration rate of liquid methionine continues to rise, and special products have achieved double-digit sales growth, leading to steady overall revenue growth in the first three quarters of 2025 [1] Group 2: Project Development - The overseas liquid egg bottleneck project, the special feed additive project in Burgos, Spain, the domestic Quanzhou solid egg project, and the local production capacity construction of special products in Nanjing are all progressing smoothly [1] - The thriving development of special products is viewed positively for the company's future growth prospects [1]